Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 3/2015

01-08-2015 | Editorial

Medical treatment of acromegaly in pregnancy, highlights on new reports

Author: Maria Fleseriu

Published in: Endocrine | Issue 3/2015

Login to get access

Excerpt

In this issue of Endocrine, van der Lely et al. [1] provided a well-written, extensive review of all reported cases of pegvisomant use in pregnancy, (mother and father) from a large safety database. …
Literature
1.
2.
3.
L. Katznelson, E.R. Laws Jr, S. Melmed et al., Acromegaly: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99, 3933–3951 (2014)PubMedCrossRef
4.
5.
P.B. Araujo, L.V. Neto, M.R. Gadelha, Pituitary Tumor Management in Pregnancy. Endocrinol. Metab. Clin. North Am. 44, 181–197 (2015)PubMedCrossRef
6.
S. Cheng, L. Grasso, J.A. Martinez-Orozco et al., Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature. Clin. Endocrinol. (Oxf) 76, 264–271 (2012)CrossRef
7.
V. Cheng, C. Faiman, L. Kennedy et al., Pregnancy and acromegaly: a review. Pituitary 15, 59–63 (2012)PubMedCrossRef
8.
R. Cozzi, R. Attanasio, M. Barausse, Pregnancy in acromegaly: a one-center experience. Eur. J. Endocrinol. 155, 279–284 (2006)PubMedCrossRef
9.
M. Dias, C. Boguszewski, M. Gadelha et al., Acromegaly and pregnancy: a prospective study. Eur. J. Endocrinol. 170, 301–310 (2014)PubMedCrossRef
10.
A. Giustina, Optimal use of pegvisomant in acromegaly: are we getting there? Endocrine 48, 3–8 (2015)PubMedCrossRef
11.
S.R. Brian, M. Bidlingmaier, M.P. Wajnrajch, S.A. Weinzimer, S.E. Inzucchi, Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects. J. Clin. Endocrinol. Metab. 92, 3374–3377 (2007)PubMedCrossRef
12.
A. Qureshi, E. Kalu, G. Ramanathan et al., IVF/ICSI in a woman with active acromegaly: successful outcome following treatment with pegvisomant. J. Assist. Reprod. Genet. 23, 439–442 (2006)PubMedCentralPubMedCrossRef
13.
A.J. van der Lely, B.M. Biller, T. Brue et al., Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY. J. Clin. Endocrinol. Metab. 97, 1589–1597 (2012)PubMedCrossRef
Metadata
Title
Medical treatment of acromegaly in pregnancy, highlights on new reports
Author
Maria Fleseriu
Publication date
01-08-2015
Publisher
Springer US
Published in
Endocrine / Issue 3/2015
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-015-0603-0

Other articles of this Issue 3/2015

Endocrine 3/2015 Go to the issue

Pros and Cons in Endocrine Practice

Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros

Editorial

High salt intake: detrimental not only for blood pressure, but also for bone health?

Endocrine Imaging

Diabetic Charcot neuroarthropathy of the knee in a patient with type-1 diabetes mellitus

Mini Review

Ovarian tumors secreting insulin

Original Article

Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire

Endocrine Imaging

Pituitary stalk interruption and olfactory bulbs aplasia/hypoplasia in a man with Kallmann syndrome and reversible gonadotrope and somatotrope deficiencies
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits